Hi Everyone I receive a daily email from a financial mailing list, it is never usually identified as spam, however, they today made the mistake of capitalising the subject line of the email, but the really killer was the (apparent) reference to 'impotence'; this sent it over the edge with an extra 2.9 points!
Strange thing is, I can't find any reference to impotence in the email, nor the HTML source code. See attached. Gareth Lunchtime Fool <[EMAIL PROTECTED]> wrote .. > This mail is probably spam. The original message has been attached > along with this report, so you can recognize or block similar unwanted > mail in future. See http://spamassassin.org/tag/ for more details. > > Content preview: IF YOU ARE READING THIS, YOU MAY NOT HAVE A MIME > VERSION 1.0 COMPATIBLE MAIL READER. TO CONVERT YOUR SUBSCRIPTION TO > PLAIN TEXT OR TO UNSUBSCRIBE, SEND AN EMAIL TO [EMAIL PROTECTED] OR VISIT > http://www.fool.com/community/freemail/freemaillogin.asp [...] > > Content analysis details: (8.60 points, 5 required) > LOW_INTEREST (2.0 points) BODY: Lower Interest Rates > NO_FEE (0.2 points) BODY: No Fees > IMPOTENCE (2.9 points) BODY: Impotence cure > OFFERS_ETC (0.8 points) BODY: Stop with the offers, coupons, discounts > etc! > HTML_40_50 (1.1 points) BODY: Message is 40% to 50% HTML > HTML_MESSAGE (0.1 points) BODY: HTML included in message > HTML_FONT_BIG (0.3 points) BODY: FONT Size +2 and up or 3 and up > SUBJ_ALL_CAPS (1.1 points) Subject is all capitals > CLICK_BELOW (0.1 points) Asks you to click below > > The original message did not contain plain text, and may be unsafe to > open with some email clients; in particular, it may contain a virus, > or confirm that your address can receive spam. If you wish to view > it, it may be safer to save it to a file and open it with an editor.
--- Begin Message --- Title: The Motley Fool UK: Lunchtime Fool
![]()
The Ideal Qualiport Share
12 August 2003
Featured Fool Centre: Index Trackers
Prosper From A Stock Market Revival Want the cheapest way of benefiting from a long-term revival in shares? Want to beat the returns of 80% of fund managers? Get an index tracker through the Fool.
The Ideal Qualiport Share
What exactly does the Qualiport consider when looking for quality shares? Here's the checklist.
Sex Tip For Investors
Pfizer shareholders all know there's a growing market for the treatment of erectile dysfunction. Futura Medical is a share that could benefit.
Spending Up, Bankruptcies Up
The national spending spree courtesy of low interest rates on lending is fuelling bankruptcies.
IMIWeb IMIWeb allows you to trade shares online through nine international stock exchanges - all for a flat fee of £10 per UK trade & £15 per overseas trade. There are no management fees & no annual charges and now you can claim up to £60 cash back when you transfer your account from another broker.
Better Home Improvement Decisions
Whatever you do to improve your home, remember that you may not be able to take it with you when you sell up.
Don't Reach For The Sky
Five years ago it was found that 50% of Britons wanted digital television. But now that nearly half of the UK's household have digital TV, BSkyB could find it much harder to grow.
Hype, Spam and Penny Stocks
Starting in July 2002, Bill Mann began tracking penny stocks whenever he received an email hyping one. Out of 27 "stocks," 6 no longer exist and the average loss exceeds 80%.
Sky Slips On Results
In a flat market, Sky slips as it records a £260m profit while ScS Upholstery suffers from the hot weather.
IMIWeb IMIWeb allows you to trade shares online through nine international stock exchanges - all for a flat fee of £10 per UK trade & £15 per overseas trade. There are no management fees & no annual charges and now you can claim up to £60 cash back when you transfer your account from another broker.
![]()
More Newsletters: Weekly Digest
Monthly Newsletter
Fool Partner Offers
SIGN UP NOW!
Did you enjoy this?
Forward it to a friend
SUBSCRIPTION SERVICES : Subscribe, unsubscribe, change email format
Copyright ©1998-2003 The Motley Fool Limited. All rights reserved. Disclaimer
--- End Message ---